Top Markets
#1 MowCat MowCat +48.91%
#2 Velvet Velvet +26.35%
#3 Bermuda Shorts Bermuda Shorts +24.91%
#4 Biconomy Biconomy +20.63%
#5 Derive Derive +20.62%
#6 Quack AI Quack AI +19.12%
#7 Audiera Audiera +18.88%
#8 aPriori aPriori +18.67%
#9 Geodnet Geodnet +11.70%
#10 DUSK Network DUSK Network +9.97%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
ANG Lifesciences India Limited ANG Lifesciences India Limited

ANG Lifesciences India Limited

ANG
株式のランク #35050
ANG Lifesciences India Ltd. specializes in the creation and distribution of... ANG Lifesciences India Ltd. specializes in the creation and distribution of finished pharmaceutical products, specifically sterile dry powder intended for injection vials. The company's diverse product line includes sterile dry powder vials for treatments such as antibiotics, anti-ulcer medications, glucocorticoids, anti-inflammatory agents, anti-malarial drugs, and anesthetics. Rajesh Gupta founded the company on June 14, 2006, and its main corporate office is situated in Amritsar, India.
株価
$0.34674726
最終同期: 2026-08-14
時価総額
$4.53M
変化（1日）
0.00%
変化（1年）
6.69%
国
IN
取引 ANG Lifesciences India Limited (ANG)

カテゴリー

Healthcare
ANG Lifesciences India Limited（ANG）の利益
2026 時点の利益 TTM: 0
ANG Lifesciences India Limited の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
ANG Lifesciences India Limited の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US